Cloud Banner

Healthcare

Image

Global Transarterial Chemoembolization (TACE) Market – Industry Trends and Forecast to 2028

  • Healthcare
  • Upcoming Report
  • Jan 2021
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Transarterial Chemoembolization (TACE) Market, By Procedure Type (Conventional TACE, DEB-TACE), Product Type (Chemotherapeutic Agents, Radiotherapeutic Agents, Drug-eluting Particles), Indication (Unresectable HCC, Early-Stage HCC), End-User (Hospitals & Clinics, Cancer Research Centers), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2028

Transarterial Chemoembolization (TACE) Market Market Analysis and Insights of Global Transarterial Chemoembolization (TACE) Market

Global transarterial chemoembolization (TACE) market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to USD 3,404.56 million by 2028 growing at a CAGR of 8.25% in the above-mentioned forecast period. Increasing expenditure in pharmaceutical industries and research and development has resulted in driving the transarterial chemoembolization (TACE) market.

Transarterial chemoembolization is a process to treat liver cancer. It works on basis of blocking the blood supply to the tumour. Once the supply is blocked,  chemotherapy is given right into the tumour. It is a therapy for the patients with intermediate-stage hepatocellular carcinoma (HCC). Conventional transarterial chemoembolization is considered as a standard treatment for HCC. Transarterial chemoembolization also uses microspheres as drug carriers, which helps to reduce the concentration of chemotherapeutic in the systemic circulation of patients.

Growing prevalence of hepatocellular carcinoma (HCC) has an annual surge of approximately 750,000 cases per year worldwide. Its graphs continues to increase due to the incidence of hepatitis B virus (HBV) and hepatitis C virus (HCV) infections. Constant growth of drug consumption and development is another driving factor for transarterial chemoembolization (TACE) market.

Complications after embolization and a higher cost of treatment is a challenge for transarterial chemoembolization (TACE) market. However, death of a skilled professional during the treatment is expected to restrain the market growth during the forecast period of 2021-2028.

This transarterial chemoembolization (TACE) market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on Data Bridge Market Research transarterial chemoembolization (TACE) market contact us for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Transarterial Chemoembolization (TACE) Market Scope and Market Size

Transarterial chemoembolization (TACE) market is segmented on the basis of procedure type, product type, indication and end-user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

  • Based on procedure type, the transarterial chemoembolization (TACE) market is segmented into conventional TACE and DEB-TACE.
  • Based on product type, the transarterial chemoembolization (TACE) market is segmented into chemotherapeutic agents, radiotherapeutic agents and drug-eluting particles.
  • Transarterial chemoembolization (TACE) market is also segmented on basis of indication into unresectable HCC and early-stage HCC.
  • On the basis of end-user, the transarterial chemoembolization (TACE) market is segmented into hospitals & clinics and cancer research centers.

Transarterial Chemoembolization (TACE) Market Country Level Analysis

Transarterial chemoembolization (TACE) market is analysed and market size insights and trends are provided by country, procedure type, product type, indication and end-user as referenced above.

The countries covered in the transarterial chemoembolization (TACE) market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is likely to lead the transarterial chemoembolization (TACE) market. Increasing awareness about HCC (hepatocellular carcinoma) and early diagnosis for the disease are also boosting the transarterial chemoembolization (TACE) market in this country. Increased research and development funding is also propelling the transarterial chemoembolization (TACE) market growth in the region. The market in Asia-Pacific is expected to exhibit a substantial growth rate during the forecast period 2021-2028 due to the increasing rate of HCC in this region. Hepatitis C remains the main factor in Japan while hepatocellular carcinoma is attributable to hepatitis B virus which covers most of Asia.

The country section of the transarterial chemoembolization (TACE) market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

Transarterial chemoembolization (TACE) market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment’s, installed base of different kind of products for transarterial chemoembolization (TACE) market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the transarterial chemoembolization (TACE) market. The data is available for historic period 2010 to 2019.

Competitive Landscape and Transarterial Chemoembolization (TACE) Market Share Analysis

Transarterial chemoembolization (TACE) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to transarterial chemoembolization (TACE) market.

The major players covered in the transarterial chemoembolization (TACE) market report are Questex LLC., Siemens Healthcare GmbH, Intermountain Healthcare, Provincial Health Services Authority, Cancer Research Institute, Advaxis Inc., Bellicum Pharmaceuticals Inc., Boston Scientific Corporation, Cook, Hikma Pharmaceuticals PLC, Isofol Medical AB (publ) Biotech Center , Nippon Kayaku Co. Ltd., Novartis AG, Pfizer Inc., Sirtex SIR-Spheres Pty Ltd., Spectrum Pharmaceuticals, Inc., F. Hoffmann-La Roche Ltd, CELGENE CORPORATION, Bayer AG, Hepion Pharmaceuticals , Polaris Pharmaceuticals, Chugai Pharmaceutical Co., Ltd., and Merck & Co., Inc. among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials